Akebia Therapeutics to Present at the Jefferies Global Healthcare Conference 2025

About this update from Akebia Therapeutics, Inc.

CAMBRIDGE, Mass. , May 28, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that Akebia Executive Management will participate in a Fireside Chat at the Jefferies Global Healthcare Conference on Thursday, June 5 at 8:45 AM EDT . A webcast of the presentation can be accessed through the “Investors” section of Akebia’s website at https://ir.akebia.com following the conference. The Jefferies Global Healthcare Conference will take place June 3-5, 2025 , in New York City . About Akebia Therapeutics Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts . For more information, please visit our website at www.akebia.com , which does not form a part of this release. Akebia Therapeutics Contact Mercedes Carrasco [email protected] Source: Akebia Therapeutics, Inc.

View stock analysis, news, and events for Akebia Therapeutics, Inc.